Henri Beaufour (born January 6, 1965[1]) is a French businessman and billionaire. He is a descendant of Henri Beaufour, founder of the Beaufour laboratories, forerunner of the French biopharmaceutical company Ipsen.[2]
Henri Beaufour | |
|---|---|
| Born | Henri Pierre Albert Marie Beaufour January 1965 (age 59) |
| Nationality | French |
| Alma mater | Georgetown University |
| Board member of | Ipsen |
| Parent | Albert Beaufour |
| Relatives | Anne Beaufour (sister) |
Biography edit
Born in January 1965, in Neuilly-sur-Seine, Henri Beaufour is the son of Albert Beaufour, who died in 2000, and the grandson of Dr. Henri Beaufour, founder of the Ipsen group.[2]
He holds a bachelor's of arts from Georgetown University (Washington, D.C.).
When Albert Beaufour died in 2000, the 76% of the capital held by the family was divided between the three brothers and sisters. One of the daughters, Véronique Beaufour, sold her share, representing 6% of the capital. Anne and her brother Henri Beaufour thus control 57% of the Ipsen group, and both sit on the Board of Directors of Ipsen and Mayroy, the Ipsen controlling holding company. Their share in Ipsen is still 52% in 2020.[3]
References edit
- ^ https://find-and-update.company-information.service.gov.uk/company/01749071/filing-history?page=5
- ^ a b Mariette Finet & Elisabeth Hennebert (2012). From Beaufour to Ipsen. Qualibris edition.
- ^ "Un nouveau président pour Beaufour-Ipsen". Les Echos (in French). 2001-12-05. Retrieved 2022-12-13.
- ^ "Henri Beaufour". Forbes. Retrieved 2022-12-13.
- ^ Challenges (2022-06-06). "Anne Beaufour et Henri Beaufour ainsi que leur famille - Les 500 plus grandes fortunes de France". Challenges (in French). Retrieved 2022-12-13.
 | This French business–related biographical article is a stub. You can help Wikipedia by expanding it. |